{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:33:34Z","timestamp":1758634414433},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T00:00:00Z","timestamp":1491350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00417-017-3654-5","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T16:19:46Z","timestamp":1491409186000},"page":"1203-1211","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease"],"prefix":"10.1007","volume":"255","author":[{"given":"Un Chul","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Hwan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong Gon","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,5]]},"reference":[{"issue":"4","key":"3654_CR1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(05)80105-5","volume":"39","author":"RS Moorthy","year":"1995","unstructured":"Moorthy RS, Inomata H, Rao NA (1995) Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 39(4):265\u2013292","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"3654_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/IAE.0b013e3181eef053","volume":"31","author":"I Maruko","year":"2011","unstructured":"Maruko I, Iida T, Sugano Y, Oyamada H, Sekiryu T, Fujiwara T, Spaide RF (2011) Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina 31(3):510\u2013517. doi:\n10.1097\/IAE.0b013e3181eef053","journal-title":"Retina"},{"issue":"2\u20133","key":"3654_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10792-007-9060-y","volume":"27","author":"CP Herbort","year":"2007","unstructured":"Herbort CP, Mantovani A, Bouchenaki N (2007) Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 27(2\u20133):173\u2013182. doi:\n10.1007\/s10792-007-9060-y","journal-title":"Int Ophthalmol"},{"issue":"5","key":"3654_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9394(00)00851-5","volume":"131","author":"H Inomata","year":"2001","unstructured":"Inomata H, Rao NA (2001) Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131(5):607\u2013614","journal-title":"Am J Ophthalmol"},{"issue":"Suppl","key":"3654_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/02713689008999417","volume":"9","author":"H Inomata","year":"1990","unstructured":"Inomata H, Sakamoto T (1990) Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res 9(Suppl):35\u201340","journal-title":"Curr Eye Res"},{"issue":"1","key":"3654_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/bjophthalmol-2012-302089","volume":"97","author":"FT Silva da","year":"2013","unstructured":"da Silva FT, Sakata VM, Nakashima A, Hirata CE, Olivalves E, Takahashi WY, Costa RA, Yamamoto JH (2013) Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease. Br J Ophthalmol 97(1):70\u201374. doi:\n10.1136\/bjophthalmol-2012-302089","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"3654_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/IAE.0b013e3182a6b3f6","volume":"34","author":"H Takahashi","year":"2014","unstructured":"Takahashi H, Takase H, Ishizuka A, Miyanaga M, Kawaguchi T, Ohno-Matsui K, Mochizuki M (2014) Choroidal thickness in convalescent vogt-koyanagi-harada disease. Retina 34(4):775\u2013780. doi:\n10.1097\/IAE.0b013e3182a6b3f6","journal-title":"Retina"},{"issue":"1","key":"3654_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ajo.2008.07.044","volume":"147","author":"SP Chee","year":"2009","unstructured":"Chee SP, Jap A, Bacsal K (2009) Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol 147(1):154\u2013161 . doi:\n10.1016\/j.ajo.2008.07.044\n\n e151","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3654_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/sj.eye.6702591","volume":"22","author":"A Jap","year":"2008","unstructured":"Jap A, Luu CD, Yeo I, Chee SP (2008) Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease. Eye 22(2):240\u2013245. doi:\n10.1038\/sj.eye.6702591","journal-title":"Eye"},{"issue":"1","key":"3654_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","volume":"142","author":"RW Read","year":"2006","unstructured":"Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, Goto H, Holland GN, Kawashima H, Kojima E, Lehoang P, Lemaitre C, Okada AA, Pivetti-Pezzi P, Secchi A, See RF, Tabbara KF, Usui M, Rao NA (2006) Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 142(1):119\u2013124. doi:\n10.1016\/j.ajo.2006.02.049","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3654_CR11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9394(02)01575-1","volume":"134","author":"E Yamanaka","year":"2002","unstructured":"Yamanaka E, Ohguro N, Yamamoto S, Nakagawa Y, Imoto Y, Tano Y (2002) Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography. Am J Ophthalmol 134(3):454\u2013456","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3654_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ajo.2009.02.005","volume":"147","author":"YL Guo","year":"2009","unstructured":"Guo YL, Du Y, He JF (2009) Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease. Am J Ophthalmol 147(5):946 . doi:\n10.1016\/j.ajo.2009.02.005\n\nauthor reply 946-947","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3654_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00417-014-2710-7","volume":"253","author":"EK Lee","year":"2015","unstructured":"Lee EK, Lee SY, Yu HG (2015) A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 253(3):359\u2013368. doi:\n10.1007\/s00417-014-2710-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"3654_CR14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647\u2013652","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"3654_CR15","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","volume":"107","author":"GN Holland","year":"1989","unstructured":"Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ (1989) A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV retinopathy. Study group. Arch Ophthalmol 107(12):1759\u20131766","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"3654_CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000309240","volume":"185","author":"N Maezawa","year":"1982","unstructured":"Maezawa N, Yano A, Taniguchi M, Kojima S (1982) The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease. Ophthalmologica 185(3):179\u2013186","journal-title":"Ophthalmologica"},{"issue":"8","key":"3654_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00417-005-1156-3","volume":"243","author":"SP Chee","year":"2005","unstructured":"Chee SP, Luu CD, Cheng CL, Lim WK, Jap A (2005) Visual function in Vogt-Koyanagi-Harada patients. Graefes Arch Clin Exp Ophthalmol 243(8):785\u2013790. doi:\n10.1007\/s00417-005-1156-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"3654_CR18","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.ajo.2006.01.017","volume":"141","author":"H Keino","year":"2006","unstructured":"Keino H, Goto H, Mori H, Iwasaki T, Usui M (2006) Association between severity of inflammation in CNS and development of sunset glow fundus in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 141(6):1140\u20131142. doi:\n10.1016\/j.ajo.2006.01.017","journal-title":"Am J Ophthalmol"},{"key":"3654_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1869-5760-4-9","volume":"4","author":"H Nazari","year":"2014","unstructured":"Nazari H, Hariri A, Hu Z, Ouyang Y, Sadda S, Rao NA (2014) Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: in vivo documentation. J Ophthalmic Inflamm Infect 4:9. doi:\n10.1186\/1869-5760-4-9","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"3","key":"3654_CR20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/IAE.0b013e3182083beb","volume":"31","author":"AH Fong","year":"2011","unstructured":"Fong AH, Li KK, Wong D (2011) Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina 31(3):502\u2013509. doi:\n10.1097\/IAE.0b013e3182083beb","journal-title":"Retina"},{"issue":"7","key":"3654_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00417-011-1910-7","volume":"250","author":"K Nakai","year":"2012","unstructured":"Nakai K, Gomi F, Ikuno Y, Yasuno Y, Nouchi T, Ohguro N, Nishida K (2012) Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 250(7):1089\u20131095. doi:\n10.1007\/s00417-011-1910-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"3654_CR22","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1097\/IAE.0b013e318256205a","volume":"32","author":"M Nakayama","year":"2012","unstructured":"Nakayama M, Keino H, Okada AA, Watanabe T, Taki W, Inoue M, Hirakata A (2012) Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina 32(10):2061\u20132069. doi:\n10.1097\/IAE.0b013e318256205a","journal-title":"Retina"},{"issue":"5","key":"3654_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ajo.2008.12.008","volume":"147","author":"R Margolis","year":"2009","unstructured":"Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147(5):811\u2013815. doi:\n10.1016\/j.ajo.2008.12.008","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"3654_CR24","doi-asserted-by":"publisher","first-page":"9555","DOI":"10.1167\/iovs.11-8076","volume":"52","author":"X Ding","year":"2011","unstructured":"Ding X, Li J, Zeng J, Ma W, Liu R, Li T, Yu S, Tang S (2011) Choroidal thickness in healthy Chinese subjects. Invest Ophthalmol Vis Sci 52(13):9555\u20139560. doi:\n10.1167\/iovs.11-8076","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3654_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/eye.2008.89","volume":"23","author":"TY Lai","year":"2009","unstructured":"Lai TY, Chan RP, Chan CK, Lam DS (2009) Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye 23(3):543\u2013548. doi:\n10.1038\/eye.2008.89","journal-title":"Eye"},{"issue":"24","key":"3654_CR26","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/nejm199312093292403","volume":"329","author":"RW Beck","year":"1993","unstructured":"Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The optic neuritis study group. N Engl J Med 329(24):1764\u20131769. doi:\n10.1056\/nejm199312093292403","journal-title":"N Engl J Med"},{"issue":"11","key":"3654_CR27","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.crohns.2014.06.010","volume":"8","author":"J Llao","year":"2014","unstructured":"Llao J, Naves JE, Ruiz-Cerulla A, Marin L, Manosa M, Rodriguez-Alonso L, Cabre E, Garcia-Planella E, Guardiola J, Domenech E (2014) Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids. J Crohn\u2019s Colitis 8(11):1523\u20131528. doi:\n10.1016\/j.crohns.2014.06.010","journal-title":"J Crohn\u2019s Colitis"},{"issue":"9","key":"3654_CR28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bjo.85.9.1061","volume":"85","author":"CC Chan","year":"2001","unstructured":"Chan CC, Paine M, O\u2019Day J (2001) Steroid management in giant cell arteritis. Br J Ophthalmol 85(9):1061\u20131064","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3654_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, Keller F, Rasche FM, Haussler U (2005) Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44(1):61\u201398. doi:\n10.2165\/00003088-200544010-00003","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"3654_CR30","first-page":"652","volume":"32","author":"G Groenewoud","year":"1994","unstructured":"Groenewoud G, Hundt HK, Luus HG, Muller FO, Schall R (1994) Absolute bioavailability of a new high dose methylprednisolone tablet formulation. Int J Clin Pharmacol Ther 32(12):652\u2013654","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"3654_CR31","first-page":"131","volume":"15","author":"RW Beck","year":"1995","unstructured":"Beck RW, Trobe JD (1995) The optic neuritis treatment trial. Putting the results in perspective. The Optic Neuritis Study Group. J Neuroophthalmol 15(3):131\u2013135","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"3654_CR32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0039-128X(01)00171-4","volume":"67","author":"F Buttgereit","year":"2002","unstructured":"Buttgereit F, Scheffold A (2002) Rapid glucocorticoid effects on immune cells. Steroids 67(6):529\u2013534","journal-title":"Steroids"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3654-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-017-3654-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3654-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T06:04:03Z","timestamp":1494828243000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-017-3654-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,5]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["3654"],"URL":"https:\/\/doi.org\/10.1007\/s00417-017-3654-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,5]]}}}